According to estimations, more than 30%–50% of patients with end-stage renal disease (ESRD) have serological evidence of an active inflammatory state, such as elevated levels of CRP and pro-inflammatory cytokines. The gene discussed is CRP; the disease is stage 5 chronic kidney disease.